Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 Volatile Stocks That Could Be the Next GME

By Chris Lau, InvestorPlace Contributor

These seven volatile stocks could produce returns that rival GameStop. Investors should keep their eyes on what could be the next GME.

Fisker Could Take Market Share From Tesla, Boosting FSR Stock

By Chris Lau, InvestorPlace Contributor

FSR stock looks like a bargain, since its market capitalization is much lower than those of its competitors, including Nio and Tesla.

Only Buy CCIV Stock If You’ll Hold It For At Least 5 Years

By Chris Lau, InvestorPlace Contributor

Churchill Capital is not suitable for the short-term investor, as the Lucid acquisition will take a few years to book profits for CCIV stock.

Avoid Hyliion Holdings Stock Even If the Clean Energy Bubble Begins to Reinflate

By Chris Lau, InvestorPlace Contributor

Hyliion only rose because of the clean energy bubble as it posted no revenue in the last quarter.

Bet on Blockbuster Movies Lifting AMC Entertainment in 2021

By Chris Lau, InvestorPlace Contributor

Blockbuster releases from Disney and Warner Bros, plus the vaccine rollout are positive catalysts for AMC stock.

Load More